Outlook Therapeutics (OTLK) shares were down 61% in recent Friday premarket activity, after the company said Wednesday the US Food and Drug Administration has issued a complete response letter to the ONS-5010 biologics license application resubmission.
Intelligent Bio Solutions (INBS) stock was down 19%, partly erasing Wednesday's surge.
Nuvve (NVVE) shares were more than 8% lower after the company said Wednesday it closed a private placement of Series A convertible preferred stock and related warrants, raising gross proceeds of $5.4 million.
Kandal M Venture (FMFC) shares were down 7.1% after the leather goods producer said Wednesday its Chief Executive Ngee Woon Lim resigned and will step down on June 30.